Patent Assignment
Reel/Frame 063740/0124
Change of Name
Recorded: 2023-05-23
Pages: 3
Assignor
ANTIGEN EXPRESS, INC
Executed: 2019-12-27
Assignee
NUGENEREX IMMUNO-ONCOLOGY, INC.
450 CENTURY PKWY, SUITE 250, ALLEN, TEXAS, 75013
Covered Property
(1)
Ii-Key/Antigenic Epitope Hybrid Peptide Vaccines
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 13, 2003
From: HUMPHREYS, ROBERT; XU, MINZHEN
To: ANTIGEN EXPRESS, INC.
Reel/Frame 013651/0380 →
Security Agreement
Apr 4, 2008
From: GENEREX PHARMACEUTICALS INC.
To: SMITHFIELD FIDUCIARY LLC
Reel/Frame 020753/0662 →
Security Agreement
Apr 4, 2008
From: GENEREX PHARMACEUTICALS INC.
To: IROQUOIS CAPITAL OPPORTUNITY FUND, LP
Reel/Frame 020753/0704 →
Security Agreement
Apr 4, 2008
From: GENEREX PHARMACEUTICALS INC.
To: CRANSHIRE CAPITAL, L.P.
Reel/Frame 020753/0592 →
Security Agreement
Apr 4, 2008
From: GENEREX PHARMACEUTICALS INC.
To: ROCKMORE INVESTMENT MASTER FUND LTD.
Reel/Frame 020753/0822 →
Security Agreement
Apr 4, 2008
From: GENEREX PHARMACEUTICALS INC.
To: IROQUOIS MASTER FUND LTD.
Reel/Frame 020794/0416 →
Security Agreement
Apr 4, 2008
From: GENEREX PHARMACEUTICALS INC.
To: PORTSIDE GROWTH AND OPPORTUNITY FUND
Reel/Frame 020753/0751 →